← Back to Search

Microwave Ablation

Microwave Ablation for Liver Cancer

N/A

Waitlist Available

Research Sponsored by Ethicon, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 weeks

Awards & highlights

Study Summary

This trial will use the NEUWAVE MicroWave Ablation System with AC software to destroy soft tissue liver lesions in patients. The system will be used on patients at multiple centers during the study.

Eligible Conditions

Liver Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percentage of Lesions Where Probe Repositioning is Suggested

Percentage of Lesions Where Re-ablation is Suggested

Secondary outcome measures

Hospital Resource Utilization

Technical Success

Technique Efficacy

Other outcome measures

EORTC QLQ-C30

EORTC QLQ-HCC18

Numeric Pain Rating Scale

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Microwave AblationExperimental Treatment1 Intervention

NEUWAVE Microwave Ablation System with AC software for patients undergoing a percutaneous ablation of a soft tissue liver lesion by an interventional radiologist.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Microwave Ablation

2021

Completed Phase 2

~1650

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Ethicon, Inc.Lead Sponsor

91 Previous Clinical Trials

60,275 Total Patients Enrolled

1 Trials studying Liver Cancer

1,500 Patients Enrolled for Liver Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are included in this research endeavor?

"To complete this clinical trial, 100 eligible patients are needed. Those interested can join at Cedars-Sinai Medical Center in Los Angeles, Minnesota and Mayo Clinic in Rochester, Texas."

Answered by AI

Are new volunteers being sought for this investigation?

"Affirmative. Clinicaltrials.gov documents demonstrate that this clinical trial, which commenced on November 5th 2019, is actively seeking participants. A total of 100 individuals are required at 8 distinct medical facilities."

Answered by AI

What is the objective of this research?

"According to the clinical trial's sponsor, Ethicon Inc., this study will be assessing its primary outcome - Percentage of patients where probe repositioning is suggested- over a Day of ablation (day 0) period. Secondary parameters such as Rate of Adverse Events, Technique Efficacy and Hospital Resource Utilization #1: Time to perform the ablation procedure shall also be observed for evaluation."

Answered by AI

Is this investigation being conducted in numerous locations across North America?

"The investigation into this pharmaceutical is taking place at Cedars-Sinai Medical Centre in LA, the Mayo Clinic in Rochester, Texas and MD Anderson Cancer Centre in Houston as well as 8 other sites."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Ablation Confirmation Study

2019. "Ablation Confirmation Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03753789.